1.26 Eli Lilly soars 8% after Q1 earnings reveal surging popularity for its Zepbound weight-loss drug

<< vissza

Eli Lilly soars 8% after Q1 earnings reveal surging popularity for its Zepbound weight-loss drug
Dátum: 2024-05-01 [news.yahoo.com]

A TELJES HÍR ELOLVASÁSA >>
×